Strides Pharma Science LtdNSE: STAR

Strides Pharma Science Ltd Press Release Aug 19 2026

Aug 19, 2026 at 10:13 AM EDT · Issued by Strides Pharma Science Ltd via NSE India

Filed with NSE · Aug 19, 2026 at 10:13 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/strides-pharma-science-ltd-press-release-aug-19-2026

Release

Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 19, 2026, titled "Strides receives USFDA Establishment Inspection Report (EIR) for flagship facility in Bengaluru".

Strides Pharma Science Ltd on 6ix

Earlier from Strides Pharma Science

Later from Strides Pharma Science

Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 29, 2026, titled "Strides Delivers Strong Performance with Q2FY27 Revenue at ₹14,297m, Grew 17% YoYEx-US Markets Up 31% YoY; EBITDA Up 8% YoY to ₹2,509m, Crossing ₹2,500m in a Quarter for the First Time".Oct 29

All Strides Pharma Science news releases

Follow Strides Pharma Science into a list and get an email when it puts out news.

Follow Strides Pharma Science